Windlas Biotech Limited (WINDLAS.BO)
INR 1040.05
(-1.65%)
INR 1040.05
(-1.65%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.09 Billion | 609.65 Million | 91.3 Million | 114.54 Million | 250.06 Million | 186.54 Million |
| Net Income | 581.87 Million | 570.39 Million | 455.65 Million | 217.4 Million | 246.68 Million | 761.15 Million |
| Depreciation & Amortization | 134.44 Million | 123.64 Million | 121.47 Million | 129.65 Million | 92.93 Million | 105.91 Million |
| Deferred income taxes | - | -131.18 Million | -102.72 Million | - | - | - |
| Stock-based compensation | 20.67 Million | 10.08 Million | 18.13 Million | - | - | - |
| Change in working capital | 439.53 Million | 63.2 Million | -375.68 Million | -400.39 Million | -35.31 Million | -115.16 Million |
| Other non-cash items | -155.84 Million | -26.48 Million | -25.55 Million | 167.88 Million | -54.24 Million | -565.36 Million |
| Investing Cash Flow | -938.09 Million | -141.1 Million | -1.54 Billion | -201.98 Million | -143.41 Million | -52.74 Million |
| Investments in PPE | -376.84 Million | -708.9 Million | -148.04 Million | -58.47 Million | -153.1 Million | -89.54 Million |
| Acquisitions | 420 Thousand | 9.1 Million | 1.1 Million | -1.03 Billion | 140 Thousand | -1.83 Million |
| Investment purchases | -561.67 Million | -369.08 Million | -1.42 Billion | -147.43 Million | - | - |
| Sales/Maturities of investments | - | 882.28 Million | - | 1.02 Billion | 360 Thousand | 31.29 Million |
| Other Investing Activities | -543.84 Million | 45.5 Million | 25.62 Million | 16.77 Million | 9.19 Million | 7.34 Million |
| Financing Cash Flow | -141.83 Million | -437.39 Million | 1.3 Billion | 7.76 Million | -54.42 Million | -62.26 Million |
| Debt repayment | -3.35 Million | -3.35 Million | -3.88 Million | -45.75 Million | -63.47 Million | -13.47 Million |
| Dividends payments | -83.01 Million | -76.28 Million | - | - | - | - |
| Common Stock Repurchased | -40.23 Million | -271.93 Million | - | - | - | - |
| Common Stock Issuance | - | -11.37 Million | 1.65 Billion | -12.74 Million | - | 48.15 Million |
| Other Financing Activities | -13.33 Million | -74.46 Million | -345.24 Million | 66.25 Million | 9.05 Million | -96.94 Million |
| Accounts receivables | -198.35 Million | -83.63 Million | -316.73 Million | -148.35 Million | -26.06 Million | -9.75 Million |
| Accounts payables | 437.68 Million | 245.12 Million | 233.04 Million | -460.39 Million | 252 Million | -247.42 Million |
| Inventory | 125.49 Million | -160.28 Million | -172.49 Million | 100.7 Million | -302.9 Million | 104.85 Million |
| Other working capital | 74.71 Million | 61.99 Million | -119.5 Million | 107.65 Million | 41.65 Million | 37.16 Million |
| Cash at beginning of period | 36.86 Million | 5.7 Million | 159.3 Million | 180.78 Million | 128.55 Million | 71.95 Million |
| Cash at end of period | 309.45 Million | 36.86 Million | 5.7 Million | 159.3 Million | 180.78 Million | 128.55 Million |
| Capital Expenditure | -376.84 Million | -708.9 Million | -148.04 Million | -58.47 Million | -153.1 Million | -89.54 Million |
| Effect of forex changes on cash | - | - | - | 58.2 Million | - | -14.94 Million |
| Net cash flow / Change in cash | 272.59 Million | 31.16 Million | -153.6 Million | -21.48 Million | 52.23 Million | 56.6 Million |
| Free Cash Flow | 719.1 Million | -99.25 Million | -56.74 Million | 56.07 Million | 96.96 Million | 97 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 134.79 Million | 581.87 Million | 169.93 Million | 150.98 Million | 140.31 Million | 120.65 Million |
| Depreciation & Amortization | - | 134.44 Million | - | 33.89 Million | 33.29 Million | 31.89 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 7.69 Million | 20.67 Million | 20.67 Million | - | - | - |
| Change in working capital | - | 439.53 Million | - | - | - | - |
| Other non-cash items | -142.48 Million | -155.84 Million | -190.6 Million | -150.98 Million | -140.31 Million | -120.65 Million |
| Investing Cash Flow | - | -938.09 Million | - | - | - | - |
| Investments in PPE | - | -376.84 Million | - | - | - | - |
| Acquisitions | - | 420 Thousand | - | - | - | - |
| Investment purchases | - | -561.67 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -543.84 Million | - | - | - | - |
| Financing Cash Flow | - | -141.83 Million | - | - | - | - |
| Debt repayment | - | -3.35 Million | - | - | - | - |
| Dividends payments | - | -83.01 Million | - | - | - | - |
| Common Stock Repurchased | - | -40.23 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -13.33 Million | - | - | - | - |
| Accounts receivables | - | -198.35 Million | - | - | - | - |
| Accounts payables | - | 437.68 Million | - | - | - | - |
| Inventory | - | 125.49 Million | - | - | - | - |
| Other working capital | - | 74.71 Million | - | - | - | - |
| Cash at beginning of period | - | 36.86 Million | - | 274.28 Million | 133.97 Million | 36.86 Million |
| Cash at end of period | - | 309.45 Million | - | 150.98 Million | 274.28 Million | 120.65 Million |
| Capital Expenditure | - | -376.84 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 272.59 Million | - | -123.3 Million | 140.31 Million | 83.79 Million |
| Free Cash Flow | - | 719.1 Million | - | 150.98 Million | 140.31 Million | 120.65 Million |
IOLCP
0A7O
AMC
VARROC
MISHKA
KDH